Open AccessRandomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection
Author(s) -
Simiso Sokhela,
Bronwyn Bosch,
Andrew Hill,
Bryony Simmons,
Joana Woods,
Hilary Johnstone,
Godspower Akpomiemie,
Leah Ellis,
Andrew Owen,
Carmen Pérez Casas,
François Venter
Publication year - 2022
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkac266
Subject(s) - nitazoxanide , daclatasvir , sofosbuvir , medicine , randomized controlled trial , virology , ribavirin , hepatitis c virus , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom